Sign Up
Stories
Aelis Farma's 2024 Financial Calendar
Share
Akanda Corp. Funding Success
Avicanna Launches CBD Oral Formulation
Biopharma Companies Announce Public Offe...
Aligos Therapeutics Financial Disclosure
Clarify Pharma Rebrands to File Forge
Growing Allergy Diagnostics and Therapeu...
Overview
API
Aelis Farma, a clinical-stage biopharmaceutical company, has announced its 2024 financial calendar, focusing on the development of treatments for brain diseases, including cannabis use disorder and cognitive disorders including Down Syndrome.
Ask a question
How do Aelis Farma's drug candidates, AEF0117 and AEF0217, address specific brain diseases?
How does Aelis Farma's research on new innovative drugs for other disorders associated with CB1-SSi contribute to the advancement of brain disease treatments?
What potential impact could Aelis Farma's focus on brain disease treatments have on the pharmaceutical industry?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2023
Nov 2023
Dec 2023
Coverage